DENTSPLY SIRONA Inc (XRAY) Stake Lessened by Canada Pension Plan Investment Board

Share on StockTwits

Canada Pension Plan Investment Board lessened its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 21.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 217,064 shares of the medical instruments supplier’s stock after selling 58,974 shares during the quarter. Canada Pension Plan Investment Board owned about 0.10% of DENTSPLY SIRONA worth $8,192,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bank of Montreal Can boosted its holdings in shares of DENTSPLY SIRONA by 65.8% during the 3rd quarter. Bank of Montreal Can now owns 388,396 shares of the medical instruments supplier’s stock valued at $14,658,000 after acquiring an additional 154,125 shares during the last quarter. Continental Advisors LLC boosted its holdings in shares of DENTSPLY SIRONA by 60.6% during the 2nd quarter. Continental Advisors LLC now owns 92,800 shares of the medical instruments supplier’s stock valued at $4,062,000 after acquiring an additional 35,000 shares during the last quarter. QUANTRES ASSET MANAGEMENT Ltd purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at about $577,000. Nuance Investments LLC boosted its holdings in shares of DENTSPLY SIRONA by 134.6% during the 2nd quarter. Nuance Investments LLC now owns 2,174,311 shares of the medical instruments supplier’s stock valued at $95,170,000 after acquiring an additional 1,247,670 shares during the last quarter. Finally, Strs Ohio boosted its holdings in shares of DENTSPLY SIRONA by 28.4% during the 2nd quarter. Strs Ohio now owns 386,886 shares of the medical instruments supplier’s stock valued at $16,934,000 after acquiring an additional 85,558 shares during the last quarter. 96.21% of the stock is currently owned by hedge funds and other institutional investors.

In related news, insider Markus Boehringer sold 7,373 shares of the firm’s stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $37.86, for a total value of $279,141.78. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 1.93% of the company’s stock.

A number of analysts have recently issued reports on the stock. HC Wainwright set a $40.00 price target on shares of DENTSPLY SIRONA and gave the company a “hold” rating in a report on Friday, August 31st. ValuEngine raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a report on Wednesday, October 24th. BidaskClub raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Wednesday, November 21st. Goldman Sachs Group raised shares of DENTSPLY SIRONA from a “sell” rating to a “buy” rating and set a $44.00 price objective on the stock in a report on Friday, October 19th. Finally, Barrington Research reissued a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, November 9th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and six have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $51.50.

XRAY opened at $36.31 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.14 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $8.19 billion, a P/E ratio of 13.65, a price-to-earnings-growth ratio of 2.24 and a beta of 1.18. DENTSPLY SIRONA Inc has a 12-month low of $33.93 and a 12-month high of $68.47.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.08). The business had revenue of $928.40 million during the quarter, compared to analysts’ expectations of $951.58 million. DENTSPLY SIRONA had a positive return on equity of 8.68% and a negative net margin of 41.97%. The business’s quarterly revenue was down 8.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.70 EPS. On average, equities research analysts predict that DENTSPLY SIRONA Inc will post 1.97 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by BBNS and is the sole property of of BBNS. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://baseballnewssource.com/2018/12/08/dentsply-sirona-inc-xray-stake-lessened-by-canada-pension-plan-investment-board/3063980.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: Why is the conference call important?

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.